BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35608039)

  • 1. Healthcare resource utilization and costs in individuals with Huntington's disease by disease stage in a US population.
    Exuzides A; To TM; Abbass IM; Ta JT; Patel AM; Surinach A; Fuller RLM; Luo J
    J Med Econ; 2022; 25(1):722-729. PubMed ID: 35608039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthcare resource utilization and cost among individuals with late-onset versus adult-onset Huntington's disease: a claims‑based retrospective cohort study.
    To TM; Ta JT; Patel AM; Arndorfer S; Abbass IM; Gandhy R
    J Med Econ; 2023; 26(1):862-870. PubMed ID: 37350423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health care resource utilization and costs among individuals with vs without Huntington disease in a US population.
    To TM; Exuzides A; Abbass IM; Patel AM; Ta JT; Surinach A; Fuller RLM; Luo J
    J Manag Care Spec Pharm; 2022 Nov; 28(11):1228-1239. PubMed ID: 36282937
    [No Abstract]   [Full Text] [Related]  

  • 4. Healthcare utilization and direct medical costs of Huntington's disease among Medicaid beneficiaries in the United States.
    Patel AM; Chang E; Paydar C; Reddy SR
    J Med Econ; 2023; 26(1):811-820. PubMed ID: 37285853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare utilization and cost burden of Huntington's disease among Medicare beneficiaries in the United States.
    Exuzides A; Reddy SR; Chang E; Ta JT; Patel AM; Paydar C; Yohrling GJ
    J Med Econ; 2021; 24(1):1327-1336. PubMed ID: 34730477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The direct medical costs of Huntington's disease by stage. A retrospective commercial and Medicaid claims data analysis.
    Divino V; Dekoven M; Warner JH; Giuliano J; Anderson KE; Langbehn D; Lee WC
    J Med Econ; 2013 Aug; 16(8):1043-50. PubMed ID: 23789925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Productivity loss outcomes and costs among patients with cholangiocarcinoma in the United States: an economic evaluation.
    Parasuraman S; Thiel E; Park J; Teschemaker A
    J Med Econ; 2023; 26(1):454-462. PubMed ID: 36883994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of influenza in patients with cardiovascular disease who receive antiviral treatment for influenza.
    Corral M; Castro RC; To TM; Arndorfer S; Wang S; Stephens J
    J Med Econ; 2022; 25(1):1061-1067. PubMed ID: 35943115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing downstream healthcare resource utilization and costs based on prior utilization patterns of immediate-release hydrocodone.
    Ben-Joseph R; Bell JA; Chitnis A; Kansal A; Holly P; Paramore C; Wild H
    J Med Econ; 2016; 19(2):169-80. PubMed ID: 26451633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Economic Burden of End-Organ Damage Among Medicaid Patients with Sickle Cell Disease in the United States: A Population-Based Longitudinal Claims Study.
    Campbell A; Cong Z; Agodoa I; Song X; Martinez DJ; Black D; Lew CR; Varker H; Chan C; Lanzkron S
    J Manag Care Spec Pharm; 2020 Sep; 26(9):1121-1129. PubMed ID: 32597290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare resource utilization and costs in patients with myelodysplastic syndromes treated with hypomethylating agents: a SEER-Medicare analysis.
    Stein EM; Bonifacio G; Latrémouille-Viau D; Shi S; Guérin A; Wu EQ; Sadek I; Cao X
    J Med Econ; 2021; 24(1):234-243. PubMed ID: 33472483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and economic burden of Huntington's disease: a Canadian provincial public health system perspective.
    Shaw E; Mayer M; Ekwaru P; McMullen S; Graves E; Wu JW; Budd N; Maturi B; Cowling T; Mestre TA
    J Med Econ; 2022; 25(1):212-219. PubMed ID: 35073826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and economic burden of obstructive hypertrophic cardiomyopathy in the United States.
    Jain SS; Li SS; Xie J; Sutton MB; Fine JT; Edelberg JM; Gao W; Spertus JA; Cohen DJ
    J Med Econ; 2021; 24(1):1115-1123. PubMed ID: 34493144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct health care costs associated with COVID-19 in the United States.
    DeMartino JK; Swallow E; Goldschmidt D; Yang K; Viola M; Radtke T; Kirson N
    J Manag Care Spec Pharm; 2022 Sep; 28(9):936-947. PubMed ID: 35722829
    [No Abstract]   [Full Text] [Related]  

  • 15. Esketamine nasal spray for major depressive disorder with acute suicidal ideation or behavior: description of treatment access, utilization, and claims-based outcomes in the United States.
    Zhdanava M; Teeple A; Pilon D; Shah A; Caron-Lapointe G; Joshi K
    J Med Econ; 2023; 26(1):691-700. PubMed ID: 37130075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of healthcare resource utilization and costs of patients with HR+/HER2- advanced breast cancer treated with ribociclib versus other CDK4/6 inhibitors.
    Burne R; Balu S; Guérin A; Bungay R; Sin R; Paul ML
    J Med Econ; 2021; 24(1):806-815. PubMed ID: 34098827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world economic burden of metastatic castration-resistant prostate cancer before and after first-line therapy initiation.
    Kaye DR; Khilfeh I; Muser E; Morrison L; Kinkead F; Urosevic A; Lefebvre P; Pilon D; George DJ
    J Med Econ; 2024; 27(1):201-214. PubMed ID: 38204397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare resource utilization and expenditures among newly-diagnosed elderly non-valvular atrial fibrillation patients initiating oral anticoagulants.
    Chowdhury R; Franchino-Elder J; Wang L; Yuce H; Wang C; Hartaigh BO
    J Med Econ; 2019 Dec; 22(12):1338-1350. PubMed ID: 31549883
    [No Abstract]   [Full Text] [Related]  

  • 19. Characteristics and Healthcare Burden of Patients with Schizophrenia Treated in a US Integrated Healthcare System.
    Mahabaleshwarkar R; Lin D; Joshi K; Fishman J; Blair T; Hetherington T; Palmer P; Patel C; Krull C; Tcheremissine OV
    J Ment Health Policy Econ; 2021 Jun; 24(2):47-59. PubMed ID: 34151777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excess healthcare resource utilization and healthcare costs among privately and publicly insured patients with major depressive disorder and acute suicidal ideation or behavior in the United States.
    Zhdanava M; Voelker J; Pilon D; Joshi K; Morrison L; Sheehan JJ; Vermette-Laforme M; Lefebvre P; Citrome L
    J Affect Disord; 2022 Aug; 311():303-310. PubMed ID: 35597466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.